Table 5.
Clinical and Laboratory Features Associated with Increased Mortality Risk
Feature | HR (95% CI) | P Value |
---|---|---|
Univariate analysis | ||
Log sC5b-9 | 3.02 (1.48–6.15) | .002 |
ΔsC5b-9 from baseline to TA-TMA diagnosis | 1.93 (1.32–2.83) | .001 |
Maximum rUPCR | 1.01 (1.00–1.02) | .068 |
Number of injured organs | 2.40 (1.67–3.35) | .001 |
Renal replacement therapy | 40.75 (8.30–200.10) | <.001 |
Mechanical ventilation | 11.16 (3.57–34.83) | <.001 |
Seizures | 4.13 (1.17–14.53) | .027 |
Mental status changes | 3.81 (1.32–11.00) | .013 |
GI bleeding | 2.79 (0.90–8.63) | .740 |
Multivariate analysis | ||
Log sC5b-9 | 2.70 (1.23–5.90) | .013 |
Maximum rUPCR | 1.00 (0.99–1.02) | .485 |